RUNX1T1 and neoplasm: IHC assays of tumor tissue collected at the endpoints of the mouse xenograft trials showed that the group administered the EX527-ETO combination presented with the lowest and highest expression levels of the cell proliferation marker Ki-67 and the apoptosis marker cleaved caspase3, respectively.